Ongoing allergy and immunology research
Our food allergy program is an international leader in researching food allergy treatment, food allergy quality of life and best practices for the prevention, diagnosis and management of food allergy. Our team members are also active in food allergy healthcare policy and regularly serve as authors on practice management guidelines.
We collaborate with the top centers around the world to help research the latest food allergy treatments, which aim to desensitize allergic children so that they can tolerate up to 1 gram (a few kernels) of peanut, about the size of an accidental bite of something. This transformative research is part of an FDA fast-tracked effort to accelerate the development and approval of new food allergy therapies.
Our groundbreaking drug allergy program seeks to understand the most efficient way to diagnose drug allergy. With a focus on penicillin allergy, our team is investigating which children are low-risk and unlikely to benefit from penicillin allergy testing.
We conduct investigator-initiated and federal grant-funded studies, as well as donor and other sponsor-funded clinical trials for investigational treatments. We have a variety of ongoing allergy research studies including:
- Epicutaneous immunotherapy for the treatment of milk allergy
- Determining tradeoffs among health benefits, adverse events and resource use associated with food allergy treatment
- Understanding the outcomes of oral food challenges
- Understanding the effects of oral food challenges on food allergy quality of life
- Understanding maternal and early life influences, particularly nutritional factors, on the development of allergic diseases
What our allergy and immunology research means for kids
Our research aims to be practical, yet cutting edge, while maintaining a focus on helping our patients and their families. We want to help prevent and treat allergies, but also maximize the quality of our patients' and families' lives while they live with food allergy.